DOCSLIB.ORG

Supplementary Table 1: Significantly

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Table 1: Significantly Supplementary Table 1: Significantly upregulated genes in the “malignant” cluster of PNETs (p<0.05) Fold change Gene (WDEC/WDET) FEV protein 11.61 adenylate cyclase 2 (brain) 4.47 nuclear receptor subfamily 4, group A, member 2 4.45 growth arrest and DNA-damage-inducible, beta 3.28 plexin B1 3.10 neuronal PAS domain protein 2 2.92 caldesmon 1 2.81 drebrin 1 2.43 hypothetical protein BC013764 2.41 TGFB-induced factor (TALE family homeobox) 2.26 Homo sapiens cDNA FLJ12843 fis, clone NT2RP2003293, mRNA sequence 2.17 nuclear prelamin A recognition factor 2.15 chromobox homolog 4 (Pc class homolog, Drosophila) 2.14 RuvB (E coli homolog)-like 1 [Homo sapiens], mRNA sequence 2.03 latent transforming growth factor beta binding protein 4 2.02 putative glialblastoma cell differentiation-related 1.92 hypothetical protein FLJ10298 1.92 protein tyrosine phosphatase type IVA, member 1 1.90 ADP-ribosylation factor-like 4 1.88 NIMA (never in mitosis gene a)-related kinase 7 1.87 RAB11B, member RAS oncogene family 1.87 myelin transcription factor 1 1.86 centaurin, beta 2 1.83 Homo sapiens cDNA FLJ38575 fis, clone HCHON2007046, mRNA sequence 1.83 SH3 domain binding glutamic acid-rich protein like 3 1.81 immunoglobulin heavy constant gamma 3 (G3m marker) 1.77 chromobox homolog 3 (HP1 gamma homolog, Drosophila) 1.74 basic transcription element binding protein 1 1.73 H1 histone family, member X 1.73 protein phosphatase 2A, regulatory subunit B' (PR 53) 1.73 Homo sapiens cDNA FLJ30096 fis, clone BNGH41000045, mRNA sequence 1.73 KIAA0397 gene product 1.71 OK/SW-CL.4 [Homo sapiens], mRNA sequence 1.69 high-mobility group 20B 1.69 phosphoserine phosphatase 1.68 Homo sapiens mRNA; cDNA DKFZp434B142 (from clone DKFZp434B142), mRNA sequence 1.67 nuclear mitotic apparatus protein 1 1.67 hypothetical protein 628 1.66 PRKC, apoptosis, WT1, regulator 1.64 E3 ubiquitin ligase SMURF1 1.64 chromodomain protein, Y chromosome-like 1.63 hypothetical protein FLJ21839 1.62 hypothetical protein MGC2550 1.62 Suppl. Table 1 (continued) Fold Change Gene (WDEC/WDET) DAZ associated protein 2 1.61 replication factor C (activator 1) 2, 40kDa 1.60 likely ortholog of mouse tubulin, delta 1 1.59 FUS interacting protein (serine-arginine rich) 1 1.58 fetal Alzheimer antigen 1.58 hypothetical protein FLJ13910 1.58 Homo sapiens clone 23718 mRNA sequence 1.58 plectin 1, intermediate filament binding protein 500kDa 1.58 hypothetical protein MGC3260 1.58 inhibitor of growth family, member 4 1.57 transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) 1.57 high mobility group nucleosomal binding domain 3 1.57 Homo sapiens full length insert cDNA clone YY61D04, mRNA sequence 1.57 nucleoporin 62kDa 1.56 phosphoribosyl pyrophosphate synthetase-associated protein 2 1.56 PRO0974 [Homo sapiens], mRNA sequence 1.56 small nuclear RNA activating complex, polypeptide 3, 50kDa 1.56 actin, gamma 1 1.55 supervillin 1.55 glucosamine (N-acetyl)-6-sulfatase (Sanfilippo disease IIID) 1.55 polypyrimidine tract binding protein 1 1.54 calcium binding protein Cab45 precursor 1.54 hypothetical protein FLJ20294 1.53 intersectin 1 (SH3 domain protein) 1.52 Sp3 transcription factor 1.52 vacuolar protein sorting 41 (yeast) 1.51 Homo sapiens cDNA FLJ38058 fis, clone CTONG2014898, mRNA sequence 1.51 transmembrane 9 superfamily member 1 1.50 Supplementary Table 2: Significantly downregulated genes in the “malignant” cluster of PNETs (p<0.05) Fold Change Gene ((WDEC/WDET) ATP-binding cassette, sub-family C (CFTR/MRP), member 8 0.29 SH3-domain GRB2-like endophilin B1 0.41 Rag D protein 0.42 protocadherin 17 0.42 glucokinase (hexokinase 4, maturity onset diabetes of the young 2) 0.43 neuropeptide Y 0.46 hypothetical protein FLJ20559 0.46 sortilin-related receptor, L(DLR class) A repeats-containing 0.46 Homo sapiens, clone IMAGE:4133122, mRNA, mRNA sequence 0.47 pentaxin-related gene, rapidly induced by IL-1 beta 0.47 AD037 protein 0.47 Consensus includes gb:AF059180 /DEF=Homo sapiens mutant beta-globin (HBB) gene, complete cds /FEA=mRNA /DB_XREF=gi:4837722 /UG=Hs.155376 hemoglobin, beta 0.48 Homo sapiens cDNA: FLJ21930 fis, clone HEP04301, highly similar to HSU90916 Human clone 23815 mRNA sequence 0.49 growth factor receptor-bound protein 10 0.49 tyrosinase-related protein 1 0.51 alpha-methylacyl-CoA racemase 0.53 inositol 1,4,5-triphosphate receptor, type 3 0.54 FN5 protein 0.55 Hr44 antigen 0.55 phosphodiesterase 1C, calmodulin-dependent 70kDa 0.55 hemoglobin, beta 0.56 hemoglobin, delta 0.56 glutamate receptor, metabotropic 1 0.56 Hemoglobin gamma-G [Homo sapiens], mRNA sequence 0.56 Alpha one globin [Homo sapiens], mRNA sequence 0.57 hemoglobin, gamma G 0.58 hemoglobin, alpha 1 0.59 carbonic anhydrase IV 0.59 Endomucin-1 [Homo sapiens], mRNA sequence 0.60 carboxypeptidase A4 0.60 Rho guanine nucleotide exchange factor (GEF) 10 0.60 ESTs, Moderately similar to hypothetical protein FLJ20489 [Homo sapiens] [H.sapiens] 0.60 ADP-ribosylation factor 4-like 0.63 hemoglobin, alpha 2 0.63 adrenergic, alpha-2A-, receptor 0.63 Consensus includes gb:V00489 /DEF=Human alpha-globin gene with flanks /FEA=mRNA /DB_XREF=gi:28548 /UG=Hs.272572 hemoglobin, alpha 2 0.64 membrane protein, palmitoylated 1, 55kDa 0.64 lipase, hormone-sensitive 0.65 neuromedin B 0.65 a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 2 0.66 neurofibromin 2 (bilateral acoustic neuroma) 0.66 Supplementary Table 3: Significantly upregulated genes in GI carcinoids when compared to PNETs (p<0.05) Fold Change GI- Gene carcinoids/PNET extracellular matrix protein 1 28.08 solute carrier family 18 (vesicular monoamine), member 1 25.32 lectin, galactoside-binding, soluble, 4 (galectin 4) 24.04 cytochrome P450, subfamily IIIA, polypeptide 7 23.91 epidermal growth factor receptor pathway substrate 8 related protein 3 21.13 homeo box C6 20.79 forkhead box A1 14 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) 12.53 glucosidase, beta, acid 3 (cytosolic) 12.04 immunoglobulin kappa constant 11.1 cadherin 17, LI cadherin (liver-intestine) 10.6 apolipoprotein A-I 10.21 neuropeptide Y receptor Y1 9.99 Papillary thyroid carcinoma-encoded protein, mRNA sequence 9.47 hypothetical protein BC013764 9.02 anterior gradient 2 homolog (Xenepus laevis) 8.81 hephaestin 8.67 flavin containing monooxygenase 5 8.67 cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4 8.52 neurogranin (protein kinase C substrate, RC3) 8.42 HRAS-like suppressor 7.68 apolipoprotein D 7.67 Consensus includes gb:BF195104 /FEA=EST /DB_XREF=gi:11081627 /DB_XREF=est:7n15a07.x1 /CLONE=IMAGE:3564565 /UG=Hs.56729 lymphocyte-specific protein 1 7.63 tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) 7.6 serine (or cysteine) proteinase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 7.31 glycoprotein M6A 7.3 B-factor, properdin 7.14 myosin IA 6.98 immunoglobulin heavy constant mu 6.67 interferon consensus sequence binding protein 1 6.39 retinoic acid receptor responder (tazarotene induced) 3 6.38 cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 5 5.73 KIAA1054 protein 5.7 breast carcinoma amplified sequence 1 5.68 breast cancer anti-estrogen resistance 3 5.56 homeodomain only protein 5.56 T cell receptor beta locus 5.48 carboxylesterase 1 (monocyte/macrophage serine esterase 1) 5.41 KIAA0233 gene product 5.36 lymphocyte antigen 75 5.33 retinoic acid receptor responder (tazarotene induced) 1 5.3 Suppl. Table 3 (continued) Fold Change GI- Gene carcinoids/PNET Kruppel-like factor 5 (intestinal) 5.23 dopa decarboxylase (aromatic L-amino acid decarboxylase) 5.13 FEV protein 5 coagulation factor V (proaccelerin, labile factor) 4.73 sodium channel, voltage-gated, type III, alpha polypeptide 4.65 hypothetical protein DKFZp434B0417 4.62 phospholipase A2, group X 4.59 heparan sulfate (glucosamine) 3-O-sulfotransferase 1 4.42 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N- acetylgalactosaminyltransferase 10 (GalNAc-T10) 4.4 Homo sapiens mRNA; cDNA DKFZp564N1116 (from clone DKFZp564N1116), mRNA sequence 4.34 Mst3 and SOK1-related kinase 4.33 KIAA0830 protein 4.3 protocadherin LKC 4.27 absent in melanoma 1 4.07 ESTs, Moderately similar to T00636 hypothetical protein F21856_2 - human [H.sapiens] 4.05 KIAA0703 gene product 3.96 SMA5 3.92 ribonuclease, RNase A family, 4 3.91 annexin A13 3.82 fibroblast growth factor 13 3.79 hypothetical protein MGC2376 3.78 chemokine-like factor 1 3.66 hypothetical protein MGC2742 3.65 ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) 3.62 DKFZP586C1619 protein 3.58 fatty-acid-Coenzyme A ligase, long-chain 5 3.58 zinc finger protein 36, C3H type-like 2 3.52 KIAA1013 protein 3.44 latexin protein 3.44 KIAA0648 protein 3.4 kinesin family member 13B 3.37 potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 3.37 SMA3 3.35 hypothetical protein FLJ14639 3.31 S100 calcium binding protein A6 (calcyclin) 3.31 homolog of rat orphan transporter v7-3 3.29 hypothetical protein MGC4309 3.29 tumor necrosis factor, alpha-induced protein 3 3.28 inositol 1,4,5-triphosphate receptor, type 1 3.28 Homo sapiens, clone IMAGE:3659798, mRNA, mRNA sequence 3.26 Homo sapiens, clone IMAGE:3659798, mRNA, mRNA sequence 3.26 plexin C1 3.24 cytochrome P450, subfamily XXVIIA (steroid 27-hydroxylase, cerebrotendinous xanthomatosis), polypeptide 1 3.16 fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) 3.16 Suppl. Table 3 (continued) Fold Change GI- Gene carcinoids/PNET
Load more

Recommended publications
  • 291533611.Pdf
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Publications of the IAS Fellows Genome-wide identification, classification, evolutionary expansion and expression analyses of homeobox genes in rice Mukesh Jain, Akhilesh K. Tyagi and Jitendra P. Khurana Interdisciplinary Centre for Plant Genomics and Department of Plant Molecular Biology, University of Delhi South Campus, India Keywords Homeobox genes play a critical role in regulating various aspects of plant abiotic stress; homeobox genes; microarray growth and development. In the present study, we identified a total of 107 analysis; reproductive development; rice homeobox genes in the rice genome and grouped them into ten distinct (Oryza sativa) subfamilies based upon their domain composition and phylogenetic analy- Correspondence sis. A significantly large number of homeobox genes are located in the J. P. Khurana, Department of Plant duplicated segments of the rice genome, which suggests that the expansion Molecular Biology, University of Delhi South of homeobox gene family, in large part, might have occurred due to Campus, Benito Juarez Road, New Delhi segmental duplications in rice. Furthermore, microarray analysis was 110021, India performed to elucidate the expression profiles of these genes in different Fax: +91 011 24115270 tissues and during various stages of vegetative and reproductive develop- Tel: +91 011 24115126 ment. Several genes with predominant expression during various stages of E-mail: khuranaj@genomeindia.org panicle and seed development were identified. At least 37 homeobox genes (Received 6 November 2007, revised 3 were found to be differentially expressed significantly (more than two-fold; March 2008, accepted 31 March 2008) P < 0.05) under various abiotic stress conditions.
    [Show full text]
  • Anti-Rab11 Antibody (ARG41900)
    Product datasheet info@arigobio.com ARG41900 Package: 100 μg anti-Rab11 antibody Store at: -20°C Summary Product Description Goat Polyclonal antibody recognizes Rab11 Tested Reactivity Hu, Ms, Rat, Dog, Mk Tested Application IHC-Fr, IHC-P, WB Host Goat Clonality Polyclonal Isotype IgG Target Name Rab11 Antigen Species Mouse Immunogen Purified recombinant peptides within aa. 110 to the C-terminus of Mouse Rab11a, Rab11b and Rab11c (Rab25). Conjugation Un-conjugated Alternate Names RAB11A: Rab-11; Ras-related protein Rab-11A; YL8 RAB11B: GTP-binding protein YPT3; H-YPT3; Ras-related protein Rab-11B RAB25: RAB11C; CATX-8; Ras-related protein Rab-25 Application Instructions Application table Application Dilution IHC-Fr 1:100 - 1:400 IHC-P 1:100 - 1:400 WB 1:250 - 1:2000 Application Note IHC-P: Antigen Retrieval: Heat mediation was recommended. * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control Hepa cell lysate Calculated Mw 24 kDa Observed Size ~ 26 kDa Properties Form Liquid Purification Affinity purification with immunogen. Buffer PBS, 0.05% Sodium azide and 20% Glycerol. Preservative 0.05% Sodium azide www.arigobio.com 1/3 Stabilizer 20% Glycerol Concentration 3 mg/ml Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use.
    [Show full text]
  • The Title of the Article
    Mechanism-Anchored Profiling Derived from Epigenetic Networks Predicts Outcome in Acute Lymphoblastic Leukemia Xinan Yang, PhD1, Yong Huang, MD1, James L Chen, MD1, Jianming Xie, MSc2, Xiao Sun, PhD2, Yves A Lussier, MD1,3,4§ 1Center for Biomedical Informatics and Section of Genetic Medicine, Department of Medicine, The University of Chicago, Chicago, IL 60637 USA 2State Key Laboratory of Bioelectronics, Southeast University, 210096 Nanjing, P.R.China 3The University of Chicago Cancer Research Center, and The Ludwig Center for Metastasis Research, The University of Chicago, Chicago, IL 60637 USA 4The Institute for Genomics and Systems Biology, and the Computational Institute, The University of Chicago, Chicago, IL 60637 USA §Corresponding author Email addresses: XY: xyang2@uchicago.edu YH: yongh@uchicago.edu JC: jlchen27@yahoo.com JX: xiejm@seu.edu.cn XS: xsun@seu.edu.cn YL: lussier@uchicago.edu - 1 - Abstract Background Current outcome predictors based on “molecular profiling” rely on gene lists selected without consideration for their molecular mechanisms. This study was designed to demonstrate that we could learn about genes related to a specific mechanism and further use this knowledge to predict outcome in patients – a paradigm shift towards accurate “mechanism-anchored profiling”. We propose a novel algorithm, PGnet, which predicts a tripartite mechanism-anchored network associated to epigenetic regulation consisting of phenotypes, genes and mechanisms. Genes termed as GEMs in this network meet all of the following criteria: (i) they are co-expressed with genes known to be involved in the biological mechanism of interest, (ii) they are also differentially expressed between distinct phenotypes relevant to the study, and (iii) as a biomodule, genes correlate with both the mechanism and the phenotype.
    [Show full text]
  • Identification and Diagnostic Performance of a Small RNA Within the PCA3 and BMCC1 Gene Locus That Potentially Targets Mrna
    Published OnlineFirst November 12, 2014; DOI: 10.1158/1055-9965.EPI-14-0377 Research Article Cancer Epidemiology, Biomarkers Identification and Diagnostic Performance of a & Prevention Small RNA within the PCA3 and BMCC1 Gene Locus That Potentially Targets mRNA Ross M. Drayton1, Ishtiaq Rehman1, Raymond Clarke2, Zhongming Zhao3,4, Karl Pang1, Saiful Miah1, Robert Stoehr5, Arndt Hartmann5, Sheila Blizard1, Martin Lavin2, Helen E. Bryant1, Elena S. Martens-Uzunova6, Guido Jenster6, Freddie C. Hamdy7, Robert A. Gardiner2, and James W.F. Catto1 Abstract Background: PCA3 is a long noncoding RNA (lncRNA) with malignant prostatic tissues, exfoliated urinary cells from men unknown function, upregulated in prostate cancer. LncRNAs may with prostate cancer (13–273 fold change; t test P < 0.003), and be processed into smaller active species. We hypothesized this for closely correlated to PCA3 expression (r ¼ 0.84–0.93; P < 0.001). PCA3. Urinary PCA3-shRNA2 (C-index, 0.75–0.81) and PCA3 (C-index, Methods: We computed feasible RNA hairpins within the 0.78) could predict the presence of cancer in most men. PCA3- BMCC1 gene (encompassing PCA3) and searched a prostate shRNA2 knockup altered the expression of predicted target transcriptome for these. We measured expression using qRT- mRNAs, including COPS2, SOX11, WDR48, TEAD1, and Noggin. PCR in three cohorts of prostate cancer tissues (n ¼ 60), PCA3-shRNA2 expression was negatively correlated with COPS2 exfoliated urinary cells (n ¼ 484 with cancer and n ¼ 166 in patient samples (r ¼0.32; P < 0.001). controls), and in cell lines (n ¼ 22). We used in silico predictions Conclusion: We identified a short RNA within PCA3, whose and RNA knockup to identify potential mRNA targets of short expression is correlated to PCA3, which may target mRNAs transcribed RNAs.
    [Show full text]
  • Supplemental Table S1
    Entrez Gene Symbol Gene Name Affymetrix EST Glomchip SAGE Stanford Literature HPA confirmed Gene ID Profiling profiling Profiling Profiling array profiling confirmed 1 2 A2M alpha-2-macroglobulin 0 0 0 1 0 2 10347 ABCA7 ATP-binding cassette, sub-family A (ABC1), member 7 1 0 0 0 0 3 10350 ABCA9 ATP-binding cassette, sub-family A (ABC1), member 9 1 0 0 0 0 4 10057 ABCC5 ATP-binding cassette, sub-family C (CFTR/MRP), member 5 1 0 0 0 0 5 10060 ABCC9 ATP-binding cassette, sub-family C (CFTR/MRP), member 9 1 0 0 0 0 6 79575 ABHD8 abhydrolase domain containing 8 1 0 0 0 0 7 51225 ABI3 ABI gene family, member 3 1 0 1 0 0 8 29 ABR active BCR-related gene 1 0 0 0 0 9 25841 ABTB2 ankyrin repeat and BTB (POZ) domain containing 2 1 0 1 0 0 10 30 ACAA1 acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme A thiol 0 1 0 0 0 11 43 ACHE acetylcholinesterase (Yt blood group) 1 0 0 0 0 12 58 ACTA1 actin, alpha 1, skeletal muscle 0 1 0 0 0 13 60 ACTB actin, beta 01000 1 14 71 ACTG1 actin, gamma 1 0 1 0 0 0 15 81 ACTN4 actinin, alpha 4 0 0 1 1 1 10700177 16 10096 ACTR3 ARP3 actin-related protein 3 homolog (yeast) 0 1 0 0 0 17 94 ACVRL1 activin A receptor type II-like 1 1 0 1 0 0 18 8038 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 1 0 0 0 0 19 8751 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 1 0 0 0 0 20 8728 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 1 0 0 0 0 21 81792 ADAMTS12 ADAM metallopeptidase with thrombospondin type 1 motif, 12 1 0 0 0 0 22 9507 ADAMTS4 ADAM metallopeptidase with thrombospondin type 1
    [Show full text]
  • Supplementary Material for “Characterization of the Opossum Immune Genome Provides Insights Into the Evolution of the Mammalian Immune System”
    Supplementary material for “Characterization of the opossum immune genome provides insights into the evolution of the mammalian immune system” Katherine Belov1*, Claire E. Sanderson1, Janine E. Deakin2, Emily S.W. Wong1, Daniel Assange3, Kaighin A. McColl3, Alex Gout3,4, Bernard de Bono5, Terence P. Speed3, John Trowsdale5, Anthony T. Papenfuss3 1. Faculty of Veterinary Science, University of Sydney, Sydney, Australia 2. ARC Centre for Kangaroo Genomics, Research School of Biological Sciences, The Australian National University, Canberra, Australia 3. Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia 4. Department of Medical Biology, The University of Melbourne, Parkville, Australia 5. Immunology Division, University of Cambridge, Cambridge, UK *Corresponding author: K. Belov, Faculty of Veterinary Science, University of Sydney, NSW 2006, Australia ph 61 2 9351 3454, fx 61 2 9351 3957, email kbelov@vetsci.usyd.edu.au MHC paralogous regions Only 36 of the 114 genes in the opossum MHC have paralogs in one of the three paralogous regions (Supplementary Table 1). Genes represented in at least three of the four paralogous regions (13 genes) were used to compare gene order, revealing rearrangements between the four regions in opossum. Table 1: MHC genes with paralogs on opossum chromosomes 1, 2 and 3, corresponding to MHC paralogous regions on human chromosomes 9, 1 and 19 respectively. MHC Chromosome 1 Chromosome 2 Chromosome 3 (Human Chr 9) (Human Chr 1) (Human Chr 19) AGPAT1 AGPAT2 AIF1 C9orf58 ATP6V1G2 ATP6V1G1 ATP6V1G3 B3GALT4 B3GALT2 BAT1 DDX39 BAT2 KIAA0515 BAT2D1 BRD2 BRD3 BRDT BRD4 C4 C5 C3 SLC44A4 SLC44A5 SLC44A2 CLIC1 CLIC3 CLIC4 COL11A2 COL5A1 COL11A1 COL5A3 CREBL1 ATF6 DDAH2 DDAH1 DDR1 DDR2 EGFL8 EGFL7 EHMT2 EHMT1 GPX5 GPX4 MHC Class I CD1 HSPA1A HSPA5 MDC1 PRG4 NOTCH4 NOTCH1 NOTCH2 NOTCH3 PBX2 PBX3 PBX1 PBX4 PHF1 MTF2 PRSS16 DPP7 PSMB9 PSMB7 RGL2 RALGDS RGL1 RGL3 RING1 RNF2 RXRB RXRA RXRG SYNGAP1 RASAL2 TAP ABCA2 TNF/LTA/LTB TNFSF8/TNFSF15 TNFSF4 CD70/TNFSF9/ TNFSF14/ TNXB TNC TNR Table 2.
    [Show full text]
  • Rational Design of Resveratrol O-Methyltransferase for the Production of Pinostilbene
    International Journal of Molecular Sciences Article Rational Design of Resveratrol O-methyltransferase for the Production of Pinostilbene Daniela P. Herrera 1 , Andrea M. Chánique 1,2 , Ascensión Martínez-Márquez 3, Roque Bru-Martínez 3 , Robert Kourist 2 , Loreto P. Parra 4,* and Andreas Schüller 4,5,* 1 Department of Chemical and Bioprocesses Engineering, School of Engineering, Pontificia Universidad Católica de Chile, Vicuña Mackenna 4860, Santiago 7820244, Chile; dpherrer@uc.cl (D.P.H.); amchanique@uc.cl (A.M.C.) 2 Institute of Molecular Biotechnology, Graz University of Technology, Petersgasse 14, 8010 Graz, Austria; kourist@tugraz.at 3 Department of Agrochemistry and Biochemistry, Faculty of Science and Multidisciplinary Institute for Environmental Studies “Ramon Margalef”, University of Alicante, 03690 Alicante, Spain; asun.martinez@gcloud.ua.es (A.M.-M.); roque.bru@gcloud.ua.es (R.B.-M.) 4 Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Vicuña Mackenna 4860, Santiago 7820244, Chile 5 Department of Molecular Genetics and Microbiology, School of Biological Sciences, Pontificia Universidad Católica de Chile, Av. Libertador Bernardo O’Higgins 340, Santiago 8320000, Chile * Correspondence: lparraa@ing.puc.cl (L.P.P.); aschueller@bio.puc.cl (A.S.) Abstract: Pinostilbene is a monomethyl ether analog of the well-known nutraceutical resveratrol. Both compounds have health-promoting properties, but the latter undergoes rapid metabolization and has low bioavailability. O-methylation improves the stability and bioavailability of resveratrol. In plants, these reactions are performed by O-methyltransferases (OMTs). Few efficient OMTs that Citation: Herrera, D.P.; Chánique, monomethylate resveratrol to yield pinostilbene have been described so far.
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • The PAS Domain Confers Target Gene Specificity of Drosophila Bhlh/PAS Proteins
    Downloaded from genesdev.cshlp.org on October 3, 2021 - Published by Cold Spring Harbor Laboratory Press The PAS domain confers target gene specificity of Drosophila bHLH/PAS proteins Elazar Zelzer, Pablo Wappner, and Ben-Zion Shilo1 Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel Trachealess (Trh) and Single-minded (Sim) are highly similar Drosophila bHLH/PAS transcription factors. They activate nonoverlapping target genes and induce diverse cell fates. A single Drosophila gene encoding a bHLH/PAS protein homologous to the vertebrate ARNT protein was isolated and may serve as a partner for both Trh and Sim. We show that Trh and Sim complexes recognize similar DNA-binding sites in the embryo. To examine the basis for their distinct target gene specificity, the activity of Trh–Sim chimeric proteins was monitored in embryos. Replacement of the Trh PAS domain by the analogous region of Sim was sufficient to convert it into a functional Sim protein. The PAS domain thus mediates all the features conferring specificity and the distinct recognition of target genes. The normal expression pattern of additional proteins essential for the activity of the Trh or Sim complexes can be inferred from the induction pattern of target genes and binding-site reporters, triggered by ubiquitous expression of Trh or Sim. We postulate that the capacity of bHLH/PAS heterodimers to associate, through the PAS domain, with additional distinct proteins that bind target-gene DNA, is essential to confer specificity. [Key Words: Gene expression; bHLH/PAS; Trachealess; Single minded; HIF1a; ARNT; trachea; midline] Received February 20, 1997; revised version accepted July 1, 1997.
    [Show full text]
  • WO 2013/064736 Al 10 May 2013 (10.05.2013) P O P CT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2013/064736 Al 10 May 2013 (10.05.2013) P O P CT (51) International Patent Classification: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, C12N 9/10 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (21) International Application Number: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, PCT/FI2012/05 1048 ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (22) International Filing Date: NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, 3 1 October 2012 (3 1.10.2012) RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (25) Filing Language: English ZM, ZW. (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 201 16074 1 November 201 1 (01. 11.201 1) FI GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (71) Applicant: VALIO LTD [FI/FI]; Meijeritie 6, FI-00370 TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Helsinki (FI). EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (72) Inventors: RAJAKARI, Kirsi; c/o Valio Ltd, Meijeritie 6, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, FI-00370 Helsinki (FI).
    [Show full text]
  • Four-Dimensional Live Imaging of Apical Biosynthetic Trafficking Reveals a Post-Golgi Sorting Role of Apical Endosomal Intermediates
    Four-dimensional live imaging of apical biosynthetic trafficking reveals a post-Golgi sorting role of apical endosomal intermediates Roland Thuenauera,b,1,2, Ya-Chu Hsua, Jose Maria Carvajal-Gonzaleza,3, Sylvie Debordea,4, Jen-Zen Chuanga, Winfried Römerc,d, Alois Sonnleitnerb, Enrique Rodriguez-Boulana,5, and Ching-Hwa Sunga,5 aMargaret M. Dyson Vision Research Institute, Weill Medical College of Cornell University, New York, NY 10065; bCenter for Advanced Bioanalysis Linz, 4020 Linz, Austria; and cInstitute of Biology II, and dBIOSS Centre for Biological Signalling Studies, Albert-Ludwigs-University Freiburg, 79104 Freiburg, Germany Edited by Keith E. Mostov, University of California School of Medicine, San Francisco, CA, and accepted by the Editorial Board January 17, 2014 (received for review March 11, 2013) Emerging data suggest that in polarized epithelial cells newly is an important regulator of biological processes that require synthesized apical and basolateral plasma membrane proteins apical trafficking, e.g., lumen formation during epithelial tubu- traffic through different endosomal compartments en route to the logenesis (11), apical secretion of discoidal/fusiform vesicles in respective cell surface. However, direct evidence for trans-endo- bladder umbrella cells (12), and apical microvillus morphogenesis somal pathways of plasma membrane proteins is still missing and and rhodopsin localization in fly photoreceptors (13). However, the mechanisms involved are poorly understood. Here, we imaged despite the physiological importance of trans-endosomal traf- the entire biosynthetic route of rhodopsin-GFP, an apical marker in ficking, the underlying mechanisms remain largely unclear. epithelial cells, synchronized through recombinant conditional ag- Previous studies on trans-endosomal trafficking in polarized gregation domains, in live Madin-Darby canine kidney cells using epithelial cells have relied on pulse chase/cell fractionation pro- spinning disk confocal microscopy.
    [Show full text]
  • Biosynthetic Investigation of Phomopsins Reveals a Widespread Pathway for Ribosomal Natural Products in Ascomycetes
    Biosynthetic investigation of phomopsins reveals a widespread pathway for ribosomal natural products in Ascomycetes Wei Dinga, Wan-Qiu Liua, Youli Jiaa, Yongzhen Lia, Wilfred A. van der Donkb,c,1, and Qi Zhanga,b,1 aDepartment of Chemistry, Fudan University, Shanghai 200433, China; bDepartment of Chemistry, University of Illinois at Urbana–Champaign, Urbana, IL 61801; and cHoward Hughes Medical Institute, University of Illinois at Urbana–Champaign, Urbana, IL 61801 Edited by Jerrold Meinwald, Cornell University, Ithaca, NY, and approved February 23, 2016 (received for review November 24, 2015) Production of ribosomally synthesized and posttranslationally mod- dehydroaspartic acid, 3,4-dehydroproline, and 3,4-dehydrovaline ified peptides (RiPPs) has rarely been reported in fungi, even (Fig. 1A). though organisms of this kingdom have a long history as a prolific Early isotopic labeling studies showed that Ile, Pro, and Phe were source of natural products. Here we report an investigation of the all incorporated into the phomopsin scaffold (24). Because a Phe phomopsins, antimitotic mycotoxins. We show that phomopsin is a hydroxylase that can convert Phe to Tyr has not been found in fungal RiPP and demonstrate the widespread presence of a path- Ascomycetes, the labeling study seems incongruent with a ribosomal way for the biosynthesis of a family of fungal cyclic RiPPs, which we route to phomopsins, in which Tyr, not Phe, would need to be in- term dikaritins. We characterize PhomM as an S-adenosylmethionine– corporated into the phomopsin structure via a tRNA-dependent dependent α-N-methyltransferase that converts phomopsin A to pathway. Here we report our investigation of the biosynthetic path- an N,N-dimethylated congener (phomopsin E), and show that the way of phomopsins, which explains the paradoxical observations in methyltransferases involved in dikaritin biosynthesis have evolved the early labeling studies and unequivocally demonstrates that pho- differently and likely have broad substrate specificities.
    [Show full text]